Growth Metrics

Immuron (IMRN) Payables (2016 - 2025)

Immuron's quarterly Payables came in at $15294.3 in Q3 2025, down 28.39% year-on-year from $21358.5 in Q3 2024, and down 97.63% quarter-over-quarter from $644701.1 in Q2 2025.

Immuron has reported Payables for 10 years, with the latest figure at $15294.3 in Q3 2025.

  • For the quarter ending Q3 2025, Payables fell 28.39% year-over-year to $15294.3; the trailing twelve-month figure through Sep 2025 stood at $15294.3 (down 28.39% YoY), and the FY2025 full-year result was $15294.3, down 28.39% from the prior year.
  • Payables for Q3 2025 stood at $15294.3, down from $644701.1 in the prior quarter.
  • The five-year high for Payables was $842036.5 in Q4 2024, with the low at $7584.9 in Q2 2021.
  • Average Payables over 5 years is $406757.3, with a median of $490086.1 recorded in 2024.
  • Year-over-year, Payables jumped 23098.63% in 2021 and tumbled 98.58% in 2023.
  • Tracing IMRN's Payables over 5 years: stood at $552563.4 in 2021, then soared by 38.04% to $762732.0 in 2022, then plunged by 98.58% to $10838.7 in 2023, then soared by 7668.8% to $842036.5 in 2024, then tumbled by 98.18% to $15294.3 in 2025.
  • The last three Payables figures came in at $15294.3 (Q3 2025), $644701.1 (Q2 2025), and $842036.5 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 300,549.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.69 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 Immuron 1.27 Bn 1.27 Bn - 15,294.34

Historic Data

Download Data 🔒
DateValue
Sep 2, 2025 15,294.34
Jun 30, 2025 644,701.05
Dec 31, 2024 842,036.48
Sep 9, 2024 21,358.52
Jun 30, 2024 427,608.70
Dec 31, 2023 10,838.70
Sep 28, 2023 781,835.96
Aug 30, 2023 11,927.69
Jun 30, 2023 797,199.62
Dec 31, 2022 762,732.01
Aug 31, 2022 807,311.55
Jun 30, 2022 11,608.93
Dec 31, 2021 552,563.44
Jun 30, 2021 7,584.94
Dec 31, 2020 2,381.88
Sep 1, 2020 384,397.00
Jun 30, 2020 251,941.72
Dec 31, 2019 3,843.97
Jun 30, 2019 764,858.99
Dec 31, 2018 689,326.00
Sep 27, 2018 504,501.36
Aug 30, 2018 689,326.00
Jun 30, 2018 521,845.23
Dec 31, 2017 1.01 Mn
Sep 28, 2017 1.05 Mn
Aug 31, 2017 1.33 Mn
Jun 30, 2017 630,561.44
Dec 31, 2016 1.50 Mn